{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:00:46Z","timestamp":1791810046174,"version":"4.3.4"},"reference-count":90,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSNDDT"],"published-print":{"date-parts":[[2020,4,27]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>The activity of the hypothalamic-pituitary-adrenal (HPA) axis is commonly dysregulated in stress-related psychiatric disorders. Annexin A1 (ANXA1), an endogenous ligand of formyl peptide receptor (FPR) 2\/3, is a member of the family of phospholipid- and calcium-binding proteins with a well-defined role in the delayed early inhibitory feedback of glucocorticoids (GC) in the pituitary gland and implicated in the occurrence of behavioural disorders such as anxiety. \n<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The present study aimed to evaluate the potential role of ANXA1 and its main receptor, as a cellular mediator of behavioural disorders, in a model of corticosterone (CORT)-induced depression and subsequently the possible correlation between the depressive state and impairment of hippocampal memory. \n<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>To induce the depression model, wild-type (WT), ANXA1 knockout (KO), and FPR2\/3 KO mice were exposed to orally administration of CORT for 28 days dissolved in drinking water. Histological, biochemical and behavioural analyses were performed. \n<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p> FPR2\/3 KO and ANXA1 KO mice showed improvement in anxiety and depression-like behaviour compared with WT mice after CORT administration. In addition, FPR2\/3 KO and ANXA1 KO mice showed a reduction in histological alterations and neuronal death in hippocampal sections. Moreover, CORT+ FPR2\/3 KO and ANXA1 KO, exhibited an higher expression of brain derived neurotrophic factor (BDNF),  phospho-ERK, cAMP response element-binding protein (pCREB)  and a decrease of serotonin transporter expression (SERT) compared  to WT(CORT+)  mice. \n<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>In conclusion, the absence of the ANXA1 protein, even more than the absence of its main receptor (FPR 2\/3), was fundamental to the inhibitory action of GC on the HPA axis; it also maintained the hippocampal homeostasis by preventing neuronal damage associated with depression.\n<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871527319666200107094732","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T06:37:32Z","timestamp":1578551852000},"page":"27-43","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["The Role of Annexin A1 and Formyl Peptide Receptor 2\/3 Signaling in Chronic Corticosterone-Induced Depression-Like behaviors and Impairment in Hippocampal-Dependent Memory"],"prefix":"10.2174","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8545-990X","authenticated-orcid":true,"given":"Alessio Filippo","family":"Peritore","sequence":"first","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Science, University of Messina, Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7629-3132","authenticated-orcid":true,"given":"Rosalia","family":"Crupi","sequence":"additional","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Science, University of Messina, Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1019-5158","authenticated-orcid":true,"given":"Maria","family":"Scuto","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6840-3154","authenticated-orcid":true,"given":"Enrico","family":"Gugliandolo","sequence":"additional","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Science, University of Messina, Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7868-2505","authenticated-orcid":true,"given":"Rosalba","family":"Siracusa","sequence":"additional","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Science, University of Messina, Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9492-3161","authenticated-orcid":true,"given":"Daniela","family":"Impellizzeri","sequence":"additional","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Science, University of Messina, Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3980-0043","authenticated-orcid":true,"given":"Marika","family":"Cordaro","sequence":"additional","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Science, University of Messina, Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0389-3871","authenticated-orcid":true,"given":"Ramona","family":"D\u2019amico","sequence":"additional","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Science, University of Messina, Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0223-1403","authenticated-orcid":true,"given":"Roberta","family":"Fusco","sequence":"additional","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Science, University of Messina, Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6725-8581","authenticated-orcid":true,"given":"Rosanna","family":"Di Paola","sequence":"additional","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Science, University of Messina, Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6131-3690","authenticated-orcid":true,"given":"Salvatore","family":"Cuzzocrea","sequence":"additional","affiliation":[{"name":"Department of Chemical, Biological, Pharmaceutical and Environmental Science, University of Messina, Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1515\/REVNEURO.2003.14.3.253","volume":"14","author":"H\u00f6lscher C.","year":"2003","unstructured":"H\u00f6lscher C.; Time, space and hippocampal functions. Rev Neurosci 2003,14(3),253-284","journal-title":"Rev Neurosci"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0166-4328(93)90091-4","volume":"58","author":"LeDoux J.E.","year":"1993","unstructured":"LeDoux J.E.; Emotional memory systems in the brain. Behav Brain Res 1993,58(1-2),69-79","journal-title":"Behav Brain Res"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1126\/science.1193692","volume":"329","author":"Baudry A.","year":"2010","unstructured":"Baudry A.; Mouillet-Richard S.; Schneider B.; Launay J.M.; Kellermann O.; miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants. Science 2010,329(5998),1537-1541","journal-title":"Science"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1523\/JNEUROSCI.16-07-02365.1996","volume":"16","author":"Nibuya M.","year":"1996","unstructured":"Nibuya M.; Nestler E.J.; Duman R.S.; Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 1996,16(7),2365-2372","journal-title":"J Neurosci"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1523\/JNEUROSCI.17-08-02785.1997","volume":"17","author":"Vaidya V.A.","year":"1997","unstructured":"Vaidya V.A.; Marek G.J.; Aghajanian G.K.; Duman R.S.; 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J Neurosci 1997,17(8),2785-2795","journal-title":"J Neurosci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S0028-3908(03)00077-7","volume":"44","author":"Coppell A.L.","year":"2003","unstructured":"Coppell A.L.; Pei Q.; Zetterstr\u00f6m T.S.; Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology 2003,44(7),903-910","journal-title":"Neuropharmacology"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000149817","volume":"57","author":"Lee H.Y.","year":"2008","unstructured":"Lee H.Y.; Kim Y.K.; Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants. Neuropsychobiology 2008,57(4),194-199","journal-title":"Neuropsychobiology"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"13208","DOI":"10.1073\/pnas.0605180103","volume":"103","author":"Govindarajan A.","year":"2006","unstructured":"Govindarajan A.; Rao B.S.; Nair D.; Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects. Proc Natl Acad Sci USA 2006,103(35),13208-13213","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0006-8993(95)01289-3","volume":"710","author":"Siuciak J.A.","year":"1996","unstructured":"Siuciak J.A.; Boylan C.; Fritsche M.; Altar C.A.; Lindsay R.M.; BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration. Brain Res 1996,710(1-2),11-20","journal-title":"Brain Res"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1196\/annals.1410.076","volume":"1148","author":"Gourley S.L.","year":"2008","unstructured":"Gourley S.L.; Wu F.J.; Taylor J.R.; Corticosterone regulates pERK1\/2 map kinase in a chronic depression model. Ann N Y Acad Sci 2008,1148,509-514","journal-title":"Ann N Y Acad Sci"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1146\/annurev.neuro.22.1.105","volume":"22","author":"McEwen B.S.","year":"1999","unstructured":"McEwen B.S.; Stress and hippocampal plasticity. Annu Rev Neurosci 1999,22,105-122","journal-title":"Annu Rev Neurosci"},{"key":"ref=12","first-page":"401","volume":"299","author":"Duman R.S.","year":"2001","unstructured":"Duman R.S.; Malberg J.; Nakagawa S.; Regulation of adult neurogenesis by psychotropic drugs and stress. J Pharmacol Exp Ther 2001,299(2),401-407","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/87865","volume":"7","author":"Manji H.K.","year":"2001","unstructured":"Manji H.K.; Drevets W.C.; Charney D.S.; The cellular neurobiology of depression. Nat Med 2001,7(5),541-547","journal-title":"Nat Med"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S0006-3223(03)00117-3","volume":"53","author":"Manji H.K.","year":"2003","unstructured":"Manji H.K.; Quiroz J.A.; Sporn J.; Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol Psychiatry 2003,53(8),707-742","journal-title":"Biol Psychiatry"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1472-6882-11-7","volume":"11","author":"Crupi R.","year":"2011","unstructured":"Crupi R.; Mazzon E.; Marino A.; Hypericum perforatum treatment: effect on behaviour and neurogenesis in a chronic stress model in mice. BMC Complement Altern Med 2011,11,7","journal-title":"BMC Complement Altern Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"4804","DOI":"10.1210\/en.2005-0500","volume":"146","author":"Theogaraj E.","year":"2005","unstructured":"Theogaraj E.; John C.D.; Christian H.C.; Morris J.F.; Smith S.F.; Buckingham J.C.; Perinatal glucocorticoid treatment produces molecular, functional, and morphological changes in the anterior pituitary gland of the adult male rat. Endocrinology 2005,146(11),4804-4813","journal-title":"Endocrinology"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1159\/000126572","volume":"58","author":"Taylor A.D.","year":"1993","unstructured":"Taylor A.D.; Cowell A.M.; Flower J.; Buckingham J.C.; Lipocortin 1 mediates an early inhibitory action of glucocorticoids on the secretion of ACTH by the rat anterior pituitary gland in vitro. Neuroendocrinology 1993,58(4),430-439","journal-title":"Neuroendocrinology"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S1357-4310(97)88908-3","volume":"3","author":"Buckingham J.C.","year":"1997","unstructured":"Buckingham J.C.; Flower R.J.; Lipocortin 1: a second messenger of glucocorticoid action in the hypothalamo-pituitary-adrenocortical axis. Mol Med Today 1997,3(7),296-302","journal-title":"Mol Med Today"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1097\/00001756-199705260-00016","volume":"8","author":"Philip J.G.","year":"1997","unstructured":"Philip J.G.; Flower R.J.; Buckingham J.C.; Glucocorticoids modulate the cellular disposition of lipocortin 1 in the rat brain in vivo and in vitro. Neuroreport 1997,8(8),1871-1876","journal-title":"Neuroreport"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1016\/S0002-9440(10)64667-6","volume":"158","author":"Perretti M.","year":"2001","unstructured":"Perretti M.; Getting S.J.; Solito E.; Murphy P.M.; Gao J.L.; Involvement of the receptor for formylated peptides in the in vivo anti-migratory actions of annexin 1 and its mimetics. Am J Pathol 2001,158(6),1969-73","journal-title":"Am J Pathol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1124\/pr.109.001578","volume":"61","author":"Ye R.D.","year":"2009","unstructured":"Ye R.D.; Boulay F.; Wang J.M.; International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev 2009,61(2),119-161","journal-title":"Pharmacol Rev"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nri2470","volume":"9","author":"Perretti M.","year":"2009","unstructured":"Perretti M.; D\u2019Acquisto F.; Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol 2009,9(1),62-70","journal-title":"Nat Rev Immunol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.pharmthera.2010.04.010","volume":"127","author":"Dufton N.","year":"2010","unstructured":"Dufton N.; Perretti M.; Therapeutic anti-inflammatory potential of formyl-peptide receptor agonists. Pharmacol Ther 2010,127(2),175-88","journal-title":"Pharmacol Ther"},{"key":"ref=24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0114626","volume":"9","author":"Gallo I.","year":"2014","unstructured":"Gallo I.; Rattazzi L.; Piras G.; Formyl peptide receptor as a novel therapeutic target for anxiety-related disorders. PLoS One 2014,9(12)","journal-title":"PLoS One"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1096\/fj.02-0239fje","volume":"17","author":"Hannon R.","year":"2003","unstructured":"Hannon R.; Croxtall J.D.; Getting S.J.; Aberrant inflammation and resistance to glucocorticoids in annexin 1-\/- mouse. FASEB J 2003,17(2),253-255","journal-title":"FASEB J"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1159\/000442606","volume":"23","author":"Grassm\u00e9 H.","year":"2015","unstructured":"Grassm\u00e9 H.; Jernigan P.L.; Hoehn R.S.; Inhibition of acid sphingomyelinase by antidepressants counteracts stress-induced activation of P38-Kinase in Major Depression. Neurosignals 2015,23(1),84-92","journal-title":"Neurosignals"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1089\/neu.2017.5260","volume":"35","author":"Casili G.","year":"2018","unstructured":"Casili G.; Campolo M.; Paterniti I.; Dimethyl fumarate attenuates neuroinflammation and neurobehavioral deficits induced by experimental traumatic brain injury. J Neurotrauma 2018,35(13),1437-1451","journal-title":"J Neurotrauma"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.1083328","volume":"301","author":"Santarelli L.","year":"2003","unstructured":"Santarelli L.; Saxe M.; Gross C.; Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003,301(5634),805-9","journal-title":"Science"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0014-2999(79)90366-2","volume":"57","author":"Porsolt R.D.","year":"1979","unstructured":"Porsolt R.D.; Bertin A.; Blavet N.; Deniel M.; Jalfre M.; Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. Eur J Pharmacol 1979,57(2-3),201-10","journal-title":"Eur J Pharmacol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.bbr.2010.02.026","volume":"210","author":"Mao Q.Q.","year":"2010","unstructured":"Mao Q.Q.; Xian Y.F.; Ip S.P.; Tsai S.H.; Che C.T.; Long-term treatment with peony glycosides reverses chronic unpredictable mild stress-induced depressive-like behavior via increasing expression of neurotrophins in rat brain. Behav Brain Res 2010,210(2),171-7","journal-title":"Behav Brain Res"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.bbr.2010.05.034","volume":"214","author":"Botton P.H.","year":"2010","unstructured":"Botton P.H.; Costa M.S.; Ardais A.P.; Caffeine prevents disruption of memory consolidation in the inhibitory avoidance and novel object recognition tasks by scopolamine in adult mice. Behav Brain Res 2010,214(2),254-9","journal-title":"Behav Brain Res"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3389\/fneur.2017.00233","volume":"8","author":"Siracusa R.","year":"2017","unstructured":"Siracusa R.; Impellizzeri D.; Cordaro M.; Anti-inflammatory and neuroprotective effects of co-UltraPEALut in a mouse model of vascular dementia. Front Neurol 2017,8,233","journal-title":"Front Neurol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fncir.2014.00137","volume":"8","author":"Yin J.B.","year":"2014","unstructured":"Yin J.B.; Wu H.H.; Dong Y.L.; Neurochemical properties of BDNF-containing neurons projecting to rostral ventromedial medulla in the ventrolateral periaqueductal gray. Front Neural Circuits 2014,8,137","journal-title":"Front Neural Circuits"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ejphar.2016.03.033","volume":"782:","author":"Esposito E, D I, G B,","year":"2016","unstructured":"Esposito E, D I, G B,; et al. A new co-micronized composite containing palmitoylethanolamide and polydatin shows superior oral efficacy compared to their association in a rat paw model of carrageenan-induced inflammation. Eur J Pharmacol 2016,782:,107-18","journal-title":"Eur J Pharmacol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"9251","DOI":"10.1007\/s12035-018-1064-2","volume":"55","author":"Cordaro M.","year":"2018","unstructured":"Cordaro M.; Siracusa R.; Crupi R.; 2-Pentadecyl-2-oxazoline reduces neuroinflammatory environment in the MPTP model of Parkinson disease. Mol Neurobiol 2018,55(12),9251-9266","journal-title":"Mol Neurobiol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3389\/fphar.2018.00871","volume":"9","author":"Siracusa R.","year":"2018","unstructured":"Siracusa R.; Impellizzeri D.; Cordaro M.; Topical application of adelmidrol + trans-traumatic acid enhances skin wound healing in a streptozotocin-induced diabetic mouse model. Front Pharmacol 2018,9,871","journal-title":"Front Pharmacol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.tem.2004.02.001","volume":"15","author":"John C.D.","year":"2004","unstructured":"John C.D.; Christian H.C.; Morris J.F.; Flower R.J.; Solito E.; Buckingham J.C.; Annexin 1 and the regulation of endocrine function. Trends Endocrinol Metab 2004,15(3),103-109","journal-title":"Trends Endocrinol Metab"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"783","DOI":"10.2108\/zsj.27.783","volume":"27","author":"Aoki M.","year":"2010","unstructured":"Aoki M.; Shimozuru M.; Kikusui T.; Takeuchi Y.; Mori Y.; Sex differences in behavioral and corticosterone responses to mild stressors in ICR mice are altered by ovariectomy in peripubertal period. Zool Sci 2010,27(10),783-9","journal-title":"Zool Sci"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bbr.2005.10.004","volume":"168","author":"M\u00e1rquez C.","year":"2006","unstructured":"M\u00e1rquez C.; Nadal R.; Armario A.; Influence of reactivity to novelty and anxiety on hypothalamic-pituitary-adrenal and prolactin responses to two different novel environments in adult male rats. Behav Brain Res 2006,168(1),13-22","journal-title":"Behav Brain Res"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.psyneuen.2008.03.013","volume":"33","author":"Touma C.","year":"2008","unstructured":"Touma C.; Bunck M.; Glasl L.; Mice selected for high versus low stress reactivity: a new animal model for affective disorders. Psychoneuroendocrinology 2008,33(6),839-62","journal-title":"Psychoneuroendocrinology"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0166-4328(01)00292-3","volume":"125","author":"File S.E.","year":"2001","unstructured":"File S.E.; Factors controlling measures of anxiety and responses to novelty in the mouse. Behav Brain Res 2001,125(1-2),151-157","journal-title":"Behav Brain Res"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0006-8993(98)01258-X","volume":"835","author":"Crawley J.N.","year":"1999","unstructured":"Crawley J.N.; Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res 1999,835(1),18-26","journal-title":"Brain Res"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3892\/mmr.2012.1041","volume":"6","author":"Zhang H.","year":"2012","unstructured":"Zhang H.; Liu B.; Wu J.; Xu C.; Tao J.; Duan X.; Cao Y.; Dong J.; Icariin inhibits corticosterone-induced apoptosis in hypothalamic neurons via the PI3-K\/Akt signaling pathway. Mol Med Rep 2012,6(5),967-972","journal-title":"Mol Med Rep"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fncel.2012.00024","volume":"6","author":"Levy B.H.","year":"2012","unstructured":"Levy B.H.; Tasker J.G.; Synaptic regulation of the hypothalamic-pituitary-adrenal axis and its modulation by glucocorticoids and stress. Front Cell Neurosci 2012,6,24","journal-title":"Front Cell Neurosci"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1017\/S003329170002585X","volume":"17","author":"Rubin R.T.","year":"1987","unstructured":"Rubin R.T.; Poland R.E.; Lesser I.M.; Martin D.J.; Blodgett A.L.; Winston R.A.; Neuroendocrine aspects of primary endogenous depression. III. Cortisol secretion in relation to diagnosis and symptom patterns. Psychol Med 1987,17(3),609-619","journal-title":"Psychol Med"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1017\/S0033291712000955","volume":"43","author":"Herbert J.","year":"2013","unstructured":"Herbert J.; Cortisol and depression: three questions for psychiatry. Psychol Med 2013,43(3),449-469","journal-title":"Psychol Med"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2174\/1871527318666190112143834","volume":"18","author":"Zameer S.","year":"2019","unstructured":"Zameer S.; Akhtar M.; Vohora D.; Behavioral experimental paradigms for the evaluation of drug\u2019s influence on cognitive functions: interpretation of associative, spatial\/nonspatial and working memory. CNS Neurol Disord Drug Targets 2019,18(3),185-204","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2174\/1871527315666160711104719","volume":"16","author":"Yu J.Z.","year":"2017","unstructured":"Yu J.Z.; Li Y.H.; Liu C.Y.; Wang Q.; Gu Q.F.; Wang H.Q.; Zhang G.X.; Xiao B.G.; Ma C.G.; Multitarget therapeutic effect of fasudil in APP\/PS1transgenic mice. CNS Neurol Disord Drug Targets 2017,16(2),199-209","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"618","DOI":"10.2174\/1871527317666180720155300","volume":"17","author":"Al-Hakeim H.K.","year":"2018","unstructured":"Al-Hakeim H.K.; Al-Kufi S.N.; Al-Dujaili A.H.; Maes M.; Serum interleukin levels and insulin resistance in major depressive disorder. CNS Neurol Disord Drug Targets 2018,17(8),618-625","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2174\/1871527317666180515120212","volume":"17","author":"Farkhondeh T.","year":"2018","unstructured":"Farkhondeh T.; Samarghandian S.; Samini F.; Sanati A.R.; Protective effects of crocetin on depression-like behavior induced by immobilization in rat. CNS Neurol Disord Drug Targets 2018,17(5),361-369","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=51","first-page":"858","volume":"16","author":"Vazquez G.H.","year":"2017","unstructured":"Vazquez G.H.; Camino S.; Tondo L.; Baldessarini R.J.; Potential novel treatments for bipolar depression: ketamine, fatty acids, anti-inflammatory agents, and probiotics. CNS Neurol Disord Drug Targets 2017,16(8),858-869","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejphar.2008.01.014","volume":"583","author":"Murray F.","year":"2008","unstructured":"Murray F.; Smith D.W.; Hutson P.H.; Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in mice. Eur J Pharmacol 2008,583(1),115-127","journal-title":"Eur J Pharmacol"},{"key":"ref=53","first-page":"891","volume":"16","author":"Pan Z.","year":"2017","unstructured":"Pan Z.; Grovu R.C.; Cha D.S.; Carmona N.E.; Subramaniapillai M.; Shekotikhina M.; Rong C.; Lee Y.; McIntyre R.S.; Pharmacological treatment of cognitive symptoms in major depressive disorder. CNS Neurol Disord Drug Targets 2017,16(8),891-899","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1007\/s10519-011-9467-0","volume":"41","author":"Gao J.L.","year":"2011","unstructured":"Gao J.L.; Schneider E.H.; Dimitrov E.L.; Haun F.; Pham T.M.; Mohammed A.H.; Usdin T.B.; Murphy P.M.; Reduced fear memory and anxiety-like behavior in mice lacking formylpeptide receptor 1. Behav Genet 2011,41(5),724-733","journal-title":"Behav Genet"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1136\/annrheumdis-2011-201180","volume":"71","author":"Patel H.B.","year":"2012","unstructured":"Patel H.B.; Kornerup K.N.; Sampaio A.L.; D\u2019Acquisto F.; Seed M.P.; Girol A.P.; Gray M.; Pitzalis C.; Oliani S.M.; Perretti M.; The impact of endogenous annexin A1 on glucocorticoid control of inflammatory arthritis. Ann Rheum Dis 2012,71(11),1872-1880","journal-title":"Ann Rheum Dis"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/19336918.2016.1259059","volume":"11","author":"de Jong R.","year":"2017","unstructured":"de Jong R.; Leoni G.; Drechsler M.; Soehnlein O.; The advantageous role of annexin A1 in cardiovascular disease. Cell Adhes Migr 2017,11(3),261-274","journal-title":"Cell Adhes Migr"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.4049\/jimmunol.181.7.5035","volume":"181","author":"Babbin B.A.","year":"2008","unstructured":"Babbin B.A.; Laukoetter M.G.; Nava P.; Koch S.; Lee W.Y.; Capaldo C.T.; Peatman E.; Severson E.A.; Flower R.J.; Perretti M.; Parkos C.A.; Nusrat A.; Annexin A1 regulates intestinal mucosal injury, inflammation, and repair. J Immunol 2008,181(7),5035-5044","journal-title":"J Immunol"},{"key":"ref=58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19041211","volume":"19","author":"Ansari J.","year":"2018","unstructured":"Ansari J.; Kaur G.; Gavins F.N.E.; Therapeutic potential of annexin A1 in ischemia reperfusion injury. Int J Mol Sci 2018,19(4)","journal-title":"Int J Mol Sci"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.neuroscience.2008.07.041","volume":"156","author":"Leasure J.L.","year":"2008","unstructured":"Leasure J.L.; Jones M.; Forced and voluntary exercise differentially affect brain and behavior. Neuroscience 2008,156(3),456-465","journal-title":"Neuroscience"},{"key":"ref=60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081459","volume":"8","author":"Santos-Soto I.J.","year":"2013","unstructured":"Santos-Soto I.J.; Chorna N.; Carballeira N.M.; V\u00e9lez-Bartolomei J.G.; M\u00e9ndez-Merced A.T.; Chornyy A.P.; Pe\u00f1a de Ortiz S.; Voluntary running in young adult mice reduces anxiety-like behavior and increases the accumulation of bioactive lipids in the cerebral cortex. PLoS One 2013,8(12)","journal-title":"PLoS One"},{"key":"ref=61","first-page":"1867","volume":"100","author":"Fediuc S","year":"2006","unstructured":"Fediuc S; Campbell JE; Riddell MC;  Effect of voluntary wheel running on circadian corticosterone release and on HPA axis responsiveness to restraint stress in Sprague-Dawley rats. J Appl Physiol (1985) 2006,100(6),1867-75"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/j.1460-9568.2004.03587.x","volume":"20","author":"Benaroya-Milshtein N.","year":"2004","unstructured":"Benaroya-Milshtein N.; Hollander N.; Apter A.; Kukulansky T.; Raz N.; Wilf A.; Yaniv I.; Pick C.G.; Environmental enrichment in mice decreases anxiety, attenuates stress responses and enhances natural killer cell activity. Eur J Neurosci 2004,20(5),1341-1347","journal-title":"Eur J Neurosci"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0018-506X(03)00002-3","volume":"43","author":"Marashi V.","year":"2003","unstructured":"Marashi V.; Barnekow A.; Ossendorf E.; Sachser N.; Effects of different forms of environmental enrichment on behavioral, endocrinological, and immunological parameters in male mice. Horm Behav 2003,43(2),281-292","journal-title":"Horm Behav"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1258\/002367702320162379","volume":"36","author":"Olsson I.A.","year":"2002","unstructured":"Olsson I.A.; Dahlborn K.; Improving housing conditions for laboratory mice: a review of \u201cenvironmental enrichment\u201d. Lab Anim 2002,36(3),243-270","journal-title":"Lab Anim"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.neulet.2009.01.076","volume":"453","author":"Lee B.","year":"2009","unstructured":"Lee B.; Shim I.; Lee H.J.; Yang Y.; Hahm D.H.; Effects of acupuncture on chronic corticosterone-induced depression-like behavior and expression of neuropeptide Y in the rats. Neurosci Lett 2009,453(3),151-156","journal-title":"Neurosci Lett"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.steroids.2015.05.010","volume":"101","author":"Ali SH.","year":"2015","unstructured":"Ali SH.; Madhana RM, KVA, et al.Resveratrol ameliorates depressive-like behavior in repeated corticosterone-induced depression in mice. Steroids 2015,101,37-42","journal-title":"Steroids"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1096\/fj.06-7299com","volume":"21","author":"John C.D.","year":"2007","unstructured":"John C.D.; Sahni V.; Mehet D.; Morris J.F.; Christian H.C.; Perretti M.; Flower R.J.; Solito E.; Buckingham J.C.; Formyl peptide receptors and the regulation of ACTH secretion: targets for annexin A1, lipoxins, and bacterial peptides. FASEB J 2007,21(4),1037-1046","journal-title":"FASEB J"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s12640-016-9630-8","volume":"30","author":"Kurek A.","year":"2016","unstructured":"Kurek A.; Kucharczyk M.; Detka J.; \u015alusarczyk J.; Trojan E.; G\u0142ombik K.; Bojarski B.; Ludwikowska A.; Laso\u0144 W.; Budziszewska B.; Pro-apoptotic action of corticosterone in hippocampal organotypic cultures. Neurotox Res 2016,30(2),225-238","journal-title":"Neurotox Res"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.tips.2007.12.003","volume":"29","author":"Solito E.","year":"2008","unstructured":"Solito E.; McArthur S.; Christian H.; Gavins F.; Buckingham J.C.; Gillies G.E.; Annexin A1 in the brain--undiscovered roles? Trends Pharmacol Sci 2008,29(3),135-142","journal-title":"Trends Pharmacol Sci"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00011-003-1235-z","volume":"53","author":"Parente L.","year":"2004","unstructured":"Parente L.; Solito E.; Annexin 1: more than an anti-phospholipase protein. Inflamm Res 2004,53(4),125-132","journal-title":"Inflamm Res"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/sj.bjp.0704054","volume":"133","author":"Solito E.","year":"2001","unstructured":"Solito E.; de Coupade C.; Canaider S.; Goulding N.J.; Perretti M.; Transfection of annexin 1 in monocytic cells produces a high degree of spontaneous and stimulated apoptosis associated with caspase-3 activation. Br J Pharmacol 2001,133(2),217-228","journal-title":"Br J Pharmacol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41419-018-0686-7","volume":"9","author":"Xia Q.","year":"2018","unstructured":"Xia Q.; Li X.; Zhou H.; Zheng L.; Shi J.; S100A11 protects against neuronal cell apoptosis induced by cerebral ischemia via inhibiting the nuclear translocation of annexin A1. Cell Death Dis 2018,9(6),657","journal-title":"Cell Death Dis"},{"key":"ref=73","first-page":"134","volume":"31","author":"Coope J.","year":"1981","unstructured":"Coope J.; Is oestrogen therapy effective in the treatment of menopausal depression? J R Coll Gen Pract 1981,31(224),134-140","journal-title":"J R Coll Gen Pract"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1176\/ajp.154.12.1641","volume":"154","author":"Seeman M.V.","year":"1997","unstructured":"Seeman M.V.; Psychopathology in women and men: focus on female hormones. Am J Psychiatry 1997,154(12),1641-1647","journal-title":"Am J Psychiatry"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S1054-139X(02)00336-1","volume":"30","author":"Hayward C.","year":"2002","unstructured":"Hayward C.; Sanborn K.; Puberty and the emergence of gender differences in psychopathology. J Adolesc Health 2002,30(4)(Suppl.),49-58","journal-title":"J Adolesc Health"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0006-3223(03)00181-1","volume":"54","author":"Shimizu E.","year":"2003","unstructured":"Shimizu E.; Hashimoto K.; Okamura N.; Koike K.; Komatsu N.; Kumakiri C.; Nakazato M.; Watanabe H.; Shinoda N.; Okada S.; Iyo M.; Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 2003,54(1),70-75","journal-title":"Biol Psychiatry"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.psyneuen.2005.05.008","volume":"31","author":"Franklin T.B.","year":"2006","unstructured":"Franklin T.B.; Perrot-Sinal T.S.; Sex and ovarian steroids modulate brain-derived neurotrophic factor (BDNF) protein levels in rat hippocampus under stressful and non-stressful conditions. Psychoneuroendocrinology 2006,31(1),38-48","journal-title":"Psychoneuroendocrinology"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.steroids.2018.03.005","volume":"135","author":"Bai Y.","year":"2018","unstructured":"Bai Y.; Song L.; Dai G.; Xu M.; Zhu L.; Zhang W.; Jing W.; Ju W.; Antidepressant effects of magnolol in a mouse model of depression induced by chronic corticosterone injection. Steroids 2018,135,73-78","journal-title":"Steroids"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2174\/1871527316666170731102237","volume":"17","author":"Khan H.","year":"2018","unstructured":"Khan H.; Khattak S.; Mubarak M.S.; Bawazeer S.S.; Abu-Izneid T.; Kamal M.A.; Aantidepressant potential of peptides: new insights as future therapeutic. CNS Neurol Disord Drug Targets 2018,17(1),9-13","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1242\/bio.021022","volume":"6","author":"Guo J.Q.","year":"2017","unstructured":"Guo J.Q.; Deng H.H.; Bo X.; Yang X.S.; Involvement of BDNF\/TrkB and ERK\/CREB axes in nitroglycerin-induced rat migraine and effects of estrogen on these signals in the migraine. Biol Open 2017,6(1),8-16","journal-title":"Biol Open"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/sj.npp.1301571","volume":"33","author":"Martinowich K.","year":"2008","unstructured":"Martinowich K.; Lu B.; Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 2008,33(1),73-83","journal-title":"Neuropsychopharmacology"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cca.2016.11.034","volume":"464","author":"Perucci L.O.","year":"2017","unstructured":"Perucci L.O.; Vieira E.L.M.; Teixeira A.L.; Gomes K.B.; Dusse L.M.; Sousa L.P.; Decreased plasma concentrations of brain-derived neurotrophic factor in preeclampsia. Clin Chim Acta 2017,464,142-147","journal-title":"Clin Chim Acta"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"5354","DOI":"10.1523\/JNEUROSCI.23-12-05354.2003","volume":"23","author":"Kelly A.","year":"2003","unstructured":"Kelly A.; Laroche S.; Davis S.; Activation of mitogen-activated protein kinase\/extracellular signal-regulated kinase in hippocampal circuitry is required for consolidation and reconsolidation of recognition memory. J Neurosci 2003,23(12),5354-5360","journal-title":"J Neurosci"},{"key":"ref=84","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/269097","volume":"2008","author":"Soul\u00e9 J.","year":"2008","unstructured":"Soul\u00e9 J.; Penke Z.; Kanhema T.; Alme M.N.; Laroche S.; Bramham C.R.; Object-place recognition learning triggers rapid induction of plasticity-related immediate early genes and synaptic proteins in the rat dentate gyrus. Neural Plast 2008,2008","journal-title":"Neural Plast"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.2174\/1871527316666171026114043","volume":"16","author":"Chen D.","year":"2017","unstructured":"Chen D.; Peng C.; Xie X.; Chen Q.; Liu H.; Zhang S.; Wan F.; Ao H.; Low dose of anisodine hydrobromide induced neuroprotective effects in chronic cerebral hypoperfusion rats. CNS Neurol Disord Drug Targets 2017,16(10),1111-1119","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0893-133X(95)00016-7","volume":"13","author":"Mann J.J.","year":"1995","unstructured":"Mann J.J.; McBride P.A.; Malone K.M.; DeMeo M.; Keilp J.; Blunted serotonergic responsivity in depressed inpatients. Neuropsychopharmacology 1995,13(1),53-64","journal-title":"Neuropsychopharmacology"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1192\/bjp.180.1.24","volume":"180","author":"Bhagwagar Z.","year":"2002","unstructured":"Bhagwagar Z.; Whale R.; Cowen P.J.; State and trait abnormalities in serotonin function in major depression. Br J Psychiatry 2002,180,24-28","journal-title":"Br J Psychiatry"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0193-953X(05)70342-7","volume":"20","author":"Graeff F.G.","year":"1997","unstructured":"Graeff F.G.; Serotonergic systems. Psychiatr Clin North Am 1997,20(4),723-739","journal-title":"Psychiatr Clin North Am"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/jnc.12055","volume":"123","author":"Zhang J.","year":"2012","unstructured":"Zhang J.; Fan Y.; Li Y.; Zhu H.; Wang L.; Zhu M.Y.; Chronic social defeat up-regulates expression of the serotonin transporter in rat dorsal raphe nucleus and projection regions in a glucocorticoid-dependent manner. J Neurochem 2012,123(6),1054-1068","journal-title":"J Neurochem"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1742-4682-10-59","volume":"10","author":"Moreno-Ramos O.A.","year":"2013","unstructured":"Moreno-Ramos O.A.; Lattig M.C.; Gonz\u00e1lez Barrios A.F.; Modeling of the hypothalamic-pituitary-adrenal axis-mediated interaction between the serotonin regulation pathway and the stress response using a Boolean approximation: a novel study of depression. Theor Biol Med Model 2013,10,59","journal-title":"Theor Biol Med Model"}],"container-title":["CNS &amp; Neurological Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/178130","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T18:40:44Z","timestamp":1592246444000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/178130\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,27]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,4,27]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871527319666200107094732","relation":{},"ISSN":["1871-5273"],"issn-type":[{"value":"1871-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4,27]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-09-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}